HBC — Hofseth Biocare ASA Share News
0.000.00%
Last trade - 00:00- NOK548.79m
- NOK778.72m
- NOK256.34m
Brief: Hofseth Biocare Signs EU Distribution Agreement With Prinova Europe
Brief: Hofseth Biocare Q4 EBITDA Loss Widens To NOK 15.0 Mln
Brief: Hofseth BioCare Signs Working Capital Credit Line Of NOK 37 Mln
Brief: Hofseth Biocare Says Atlantic Sapphire And Co Sign LOI To Establish Joint Venture In Miami, U.S.
Brief: Hofseth Biocare Q3 EBITDA Loss Narrows To NOK 7.6 Mln
Brief: Hofseth Biocare Enters Into Consultancy Agreement With James Berger, Contemplates US Listing
Brief: Hofseth Biocare Gets Protein Hydrolysis Patent From European Patent Office
Brief: Hofseth Biocare Says Brilliant Invest Purchased 11 Mln Shares In Co From Hofseth International
Brief: Hofseth Biocare Raises About NOK 6.0 Mln Through Repair Issue
Brief: Hofseth Biocare Q2 EBITDA Loss Narrows To NOK 8.4 Million
Brief: Hofseth Biocare Completes Oversubscribed Private Placement
Brief: Hofseth Biocare Says Private Placement Of New Shares For Proceeds Of About NOK 118 Mln
Brief: Hofseth Biocare Signs Letter Of Intent With Garden Of Life In US
Brief: HBC Says On 24 May 2019, 3.4 Mln Shares Were Sold By Bonafide Global Fish Fund, Purchased By Bonafide Investment Fund - Best Catches I
Brief: Hofseth Biocare Q1 Operating Revenues Of NOK 14.7 Mln VS NOK 14.8 Mln
Brief: Hofseth Biocare Q4 Operational Loss Widens To NOK 18.7 Mln
Brief: Hofseth Biocare Introduces Nøre Nutrition As Its New Sales Company
Brief: Hofseth Biocare Q3 EBITDA Loss Widens To NOK 14.7 Mln
Brief: Hofseth Biocare: Subsequent Offering Raised Gross Proceeds Of About NOK 14.9 Mln